Ali Ataya, MD - Research

Research at a glance

Top areas of exploration

Dyspnea , 14 publications
Hypertension, Pulmonary , 6 publications
Pulmonary Alveolar Proteinosis , 5 publications
Lung , 5 publications

Research activity

116 publications

405 citations

Why is this important?

Active clinical trials

Prosera

The primary objective of the study is to determine the effect of seralutinib on improving exercise capacity in subjects with WHO Group 1 PAH who are FC II or III. The secondary objective for this trial is to determine time to clinical worsening.

Investigator: Ali Ataya
Status: Accepting Candidates
Ages: 18 Years - 75 Years
Sexes: All

Hemotag

Investigator: Ali Ataya
Status: Accepting Candidates

Evaluate the Efficacy, Safety and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder

The main objective of the study is to assess the effect of treprostinil palmitil inhalation powder (TPIP) compared with placebo on pulmonary vascular resistance.

Investigator: Ali Ataya
Status: Accepting Candidates
Ages: 18 Years - 75 Years
Sexes: All

My publications

116 publications

2025

A patient journey map for people living with autoimmune pulmonary alveolar proteinosis

Respiratory Medicine

2025

Development of New Intrapulmonary Shunts in Pulmonary Arterial Hypertension Treated with Sotatercept

American Journal of Respiratory and Critical Care Medicine

2025

Glycogen storage disease type V: delayed diagnosis of a cause of exercise intolerance in a patient with hereditary haemorrhagic telangiectasia.

BMJ case reports

鈥�

2025

The healthcare burden of pulmonary alveolar proteinosis (PAP).

Orphanet journal of rare diseases

鈥�

2024

A 35-Year-Old Woman With Placenta Previa and Postpartum Cardiovascular Collapse.

Chest

鈥�

BOB体育